# OnCo record kivu-107 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/kivu-107/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "kivu-107" ;
  schema:name "KIVU-107"@en ;
  schema:description "KIVU-107 is an experimental antibody-drug conjugate from Kivu Bioscience, in phase 1 trials for advanced solid tumours."@en ;
  schema:url <https://onco.cc/drugs/kivu-107/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://kivubioscience.com/news/kivu-bioscience-to-present-preclinical-data-on-next-generation-adc-programs-at-aacr-annual-meeting-2026/>, <https://www.gimv.com/en/node/4920>, <https://clinicaltrials.gov/search?intr=KIVU-107> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Antibody-drug conjugate (site-specific, GlycoConnect and HydraSpace)" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:targets <https://onco.cc/targets/ptk7/> ;
  onco:companies <https://onco.cc/companies/kivu-bioscience/> ;
  onco:trials <https://onco.cc/trials/nct07229313/> .